Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 12
Submit an article Journal homepage
164
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Central nervous system relapse in acute promyelocytic leukemia: a single institution experience

Vinay GuptaDepartment of Hematology, Mayo Clinic Rochester, Rochester, MN, USA
,
Wilson GonsalvesDepartment of Hematology, Mayo Clinic Rochester, Rochester, MN, USA
,
Mrinal PatnaikDepartment of Hematology, Mayo Clinic Rochester, Rochester, MN, USA
&
Naseema GangatDepartment of Hematology, Mayo Clinic Rochester, Rochester, MN, USACorrespondence[email protected]
Pages 2728-2730 | Received 25 Jan 2013, Accepted 01 Mar 2013, Published online: 16 Apr 2013

References

  • Sanz MA, Grimwade D, Tallman MS, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2009;113:1875–1891.
  • Sanz MA, Lo Coco F, Martin G, et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 2000;96:1247–1253.
  • Ji M, Chi HS, Jang S, et al. Acute promyelocytic leukemia presenting with central nervous system involvement: a report of 2 cases. Korean J Lab Med 2011;31:9–12.
  • Collins C, Knoderer H. Central nervous system involvement at the time of presentation in acute promyelocytic leukemia. Pediatr Blood Cancer 2010;54:603–605.
  • Evans GD, Grimwade DJ. Extramedullary disease in acute promyelocytic leukemia. Leuk Lymphoma 1999;33:219–229.
  • de Botton S, Sanz MA, Chevret S, et al. Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia 2006;20:35–41.
  • Montesinos P, Diaz-Mediavilla J, Deben G, et al. Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis. Haematologica 2009;94:1242–1249.
  • Ko BS, Tang JL, Chen YC, et al. Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia—the occurrence of retinoic acid syndrome is a risk factor. Leukemia 1999;13:1406–1408.
  • Akoz AG, Dagdas S, Ozet G, et al. Isolated central nervous system relapse during cytologic and molecular hematologic remission in two patients with acute promyelocytic leukemia. Hematology 2007;12: 419–422.
  • Knipp S, Gattermann N, Schapira M, et al. Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement. Leuk Res 2007;31:1585–1587.
  • Ades L, Chevret S, Raffoux E, et al. Is cytarabine useful in the treatment of acute promyelocytic leukemia?. Results of a randomized trial from the European Acute Promyelocytic Leukemia Group. J Clin Oncol 2006;24:5703–5710.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.